Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02575716
Other study ID # PSU-561330812
Secondary ID
Status Completed
Phase Phase 1
First received October 7, 2015
Last updated October 12, 2015
Start date March 2013
Est. completion date March 2014

Study information

Verified date October 2015
Source Prince of Songkla University
Contact n/a
Is FDA regulated No
Health authority Thailand: Ethical Committee
Study type Interventional

Clinical Trial Summary

The objective of this study was to evaluate intubating condition using the McGrath® VL Series 5, with and without muscle relaxant


Description:

Thirty-four patients with ASA classification I-II, who required oroendotracheal tube intubation, were studied in this prospective, double-blinded, randomized, clinical trial. Anesthesia was induced using fentanyl 1.5 mcg/kg, xylocaine 1.5 mg/kg and propofol 3 mg/kg. Patients were randomly assigned to one of the two groups to receive either rocuronium 0.6 mg/kg or saline intravenously. The Mcgrath® VL intubation was initiated after 90s, when the patients were fully relaxed. The primary outcome was to compare tracheal intubating conditions between two groups. The secondary outcomes were the success rate in the first attempt intubation, time to intubation, the required propofol dose for intubation and anesthetic complications. Statistical analyses were performed using the R program version 2.14.2. The level of statistical significance was set at p < 0.05.


Recruitment information / eligibility

Status Completed
Enrollment 34
Est. completion date March 2014
Est. primary completion date December 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Age 18-65 years old.

- ASA class I-II.

- Elective surgery required general anesthesia with oroendotracheal intubation

Exclusion Criteria:

- Suspected or known difficult airway.

- Patient with risk of aspiration with required of rapid sequence induction .

- Plan remained intubation.

- Allergic to drugs used in the study.

- Renal or hepatic disease.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Videolaryngoscope
Intubation with McGrath video laryngoscope after muscle relaxant

Locations

Country Name City State
Thailand Department of anesthesiology Hatyai Songkla

Sponsors (1)

Lead Sponsor Collaborator
Prince of Songkla University

Country where clinical trial is conducted

Thailand, 

Outcome

Type Measure Description Time frame Safety issue
Primary Intubating condition. number of participants with 34 people one year No
Secondary Success rate in the first attempt intubation. one year No
Secondary Time to intubation One year No
Secondary The required propofol dose for intubation without muscle relaxant. one year No
Secondary Events during the intubation attempts occurred. one year No
See also
  Status Clinical Trial Phase
Completed NCT03058263 - Effect of Neostigmine on the Recovery of Rocuronium: A Comparison Between Partial and TOF Ratio-Based Dose Phase 1/Phase 2
Recruiting NCT04344262 - Small Doses Muscle Relaxant in General Anesthesia N/A